Verified Nov 2026
Batteries & E-Mobility
·
Menlo Park, California
·
Since 2004
PacBio, formally Pacific Biosciences of California, Inc., is a public life science technology company headquartered in Menlo Park, California, founded in 2004 and listed under the ticker PACB. It has 200-500 employees and reports revenue in the $160M band. The company designs and manufactures DNA sequencing systems based on its Single Molecule, Real-Time (SMRT) technology, serving the life sciences, medical, and agricultural markets. In February 2026 it joined the iHope Initiative as the first long-read genomic sequencing partner.
PacBio at a glance
Revenue
160M
Employees
200-500
Founded
2004
Headquarters
Menlo Park, California
Ownership
Publicly traded (NASDAQ: PACB)
Certifications
ISO 13485 · ISO 9001
Import activity
5
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
5
Named foreign suppliers
2
Top origins
United Kingdom · Italy
Shared foreign counterparties do not establish that these companies buy from PacBio.
What this tells a buyer
PacBio completed the sale of its short-read sequencing assets on 2 February 2026, according to its own published announcements.
The company holds ISO 9001 and ISO 13485 certifications and sells sequencing instruments, SMRT Cell reagent kits, and bioinformatics software.
PacBio is publicly traded on the stock market under the ticker PACB and serves academic, clinical, pharmaceutical, and agricultural customers.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
22 years in operation (founded 2004).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
PacBio, formally Pacific Biosciences of California, Inc., is a public life science technology company headquartered in Menlo Park, California, founded in 2004 and listed under the ticker PACB. It has 200-500 employees and reports revenue in the $160M band. The company designs and manufactures DNA sequencing systems based on its Single Molecule, Real-Time (SMRT) technology, serving the life sciences, medical, and agricultural markets. In February 2026 it joined the iHope Initiative as the first long-read genomic sequencing partner.
At a glance
Attribute | Detail |
|---|---|
Founded | 2004 |
Headquarters | Menlo Park, California |
Employees | 200-500 |
Revenue | 160M |
Ownership | Publicly traded (NASDAQ: PACB) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 9001 |
What PacBio makes
The company holds ISO 9001 and ISO 13485 certifications and sells sequencing instruments, SMRT Cell reagent kits, and bioinformatics software.
Products and capabilities described on the company's own site include Semiconductor (source: pacb.com).
Certifications
PacBio is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
Trade and customs footprint
PacBio completed the sale of its short-read sequencing assets on 2 February 2026, according to its own published announcements. US customs bill-of-lading records list 5 inbound shipments across 2 foreign suppliers, with top origins including United Kingdom · Italy.
Latest developments
2026-11-04 — PacBio Announces Third Quarter 2026 Financial Results - PacBio (pacb.com)
2026-05-07 — PacBio Announces First Quarter 2026 Financial Results - PacBio (pacb.com)
2026-03-18 — Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative - PacBio (pacb.com)
2026-02-12 — PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner - PacBio (pacb.com)
2026-02-02 — PacBio Completes Sale of Short-Read Sequencing Assets - PacBio (pacb.com)
2025-10-14 — PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities - PacBio (pacb.com)
Company details
PacBio is publicly traded on the stock market under the ticker PACB and serves academic, clinical, pharmaceutical, and agricultural customers. PacBio was founded in 2004, has an estimated 200-500 employees, and is headquartered in Menlo Park, California. On the LightSource stability read it is rated "Established & strong": 22 years in operation (founded 2004). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does PacBio make?
PacBio, formally Pacific Biosciences of California, Inc., is a public life science technology company headquartered in Menlo Park, California, founded in 2004 and listed under the ticker PACB. It has 200-500 employees and reports revenue in the $160M band. The company designs and manufactures DNA sequencing systems based on its Single Molecule, Real-Time (SMRT) technology, serving the life sciences, medical, and agricultural markets. In February 2026 it joined the iHope Initiative as the first long-read genomic sequencing partner.
Where is PacBio headquartered?
PacBio is headquartered in Menlo Park, California (1305 O'Brien Drive, Menlo Park, California, 94025).
When was PacBio founded?
PacBio was founded in 2004.
How big is PacBio?
PacBio has an estimated 200-500 employees, with revenue in the 160M range.
Is PacBio publicly traded?
Publicly traded (NASDAQ: PACB). Public financial figures are drawn from its filings.
What certifications does PacBio hold?
PacBio lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.